DIFFUSE MIDLINE GLIOMA

Clinical trials for DIFFUSE MIDLINE GLIOMA explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE MIDLINE GLIOMA trials appear

Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 1

Engineered immune cells injected into the brain show promise for deadliest childhood cancers

Disease control Ongoing

This early-phase study tests a new treatment for children and young adults with diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma (DMG), and other hard-to-treat brain tumors. The therapy uses the patient's own immune cells, modified in a lab to target four different…

Matched conditions: DIFFUSE MIDLINE GLIOMA

Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

DIFFUSE MIDLINE GLIOMA

Get alerted when new DIFFUSE MIDLINE GLIOMA trials appear

Engineered immune cells injected into the brain show promise for deadliest childhood cancers